J&J Stock Falls Most in 5 Months on 2014 Profit Forecast
This article is for subscribers only.
Johnson & Johnson, the world’s biggest maker of health-care products, fell after the company’s 2014 earnings forecast was lower than analysts’ estimates.
Profit this year may be $5.75 to $5.85 a share, excluding one-time items, New Brunswick, New Jersey-based J&J said today. The outlook was below the $5.86 average of 18 analysts’ estimates compiled by Bloomberg. The stock declined 1.1 percent to close at $94.03 in New York.